1World Health Organisation. Definition, diagnosis, and classification of diabetes mellitus and its complications. report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation, 1999.
2Heldgaard PE, Olivarius Nde F, Hindsberger C. et al. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet Med
3Hanefeld M, Koehler C, Fuecker K, et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in impaired glucose tolerance for atherosclerosis and diabetes stu
4Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatmentof insulin resistance in high-risk Hispanic women. Diabetes, 2002, 51(9): 2796-2803
5Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet, 2002, 359(9323): 2072-2077
6ADA. Screening for Type 2 diabetes. Diabetes Care, 2004, 27(Suppl 1): S11-S14
7Decode Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med, 2001, 161(3): 397-405
8Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care, 1997, 20(4): 537-544
9Lindstrom J, Louheranta A, Mannelin M, et al. The finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003, 26(12): 3230-3236
10Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002, 346(6): 393-403
